Abstract
Get full access to this article
View all access options for this article.
References
1.
Prasad
V
. The same media that lied about all things COVID is lying about Peter Marks’ departure from FDA. Vinay Prasad’s Observations and thoughts (Substack feed) . 2025 . Available from: https://www.drvinayprasad.com/p/the-same-media-that-lied-about-all [Last accessed:
May 15 , 2025
].
2.
Fidler
B
. Prasad’s FDA appointment pressures cell and gene therapy stocks . BioPharma Dive , 2025 . Available from: https://www.biopharmadive.com/news/prasad-fda-gene-cell-therapy-stocks-marks/747313/ [Last accessed:
May 15 , 2025
].
3.
Prasad
V
. Post re: Verve Therapeutics’ VERVE-101 data . 2023 , 9:01 p.m. ET. Available from: https://x.com/VPrasadMDMPH/status/1725333412217856260 [Last accessed:
May 15 , 2025
].
4.
Makary
M
. Announcement of Appointment Vinay Prasad, MD, MPH, as Director of Center for Biologics Evaluation and Research. Posted on X . 2025 , 1:13 p.m. ET. Available from: https://x.com/DrMakaryFDA/status/1919802781466079264 [Last accessed:
May 15 , 2025
].
5.Sangamo Therapeutics . Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System . 2025 . Available from: https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-capsid-license-agreement-lilly [Last accessed:
May 15 , 2025
].
6.
Philippidis
A
. StockWatch: Second Time’s the Charm for Abeona’s Gene Therapy . 2025 . Available from: https://www.genengnews.com/topics/genome-editing/stockwatch-second-times-the-charm-for-abeonas-gene-therapy/ [Last accessed:
May 14 , 2025
].
7.Nuevocor . Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy . 2025 . Available from: https://www.prnewswire.com/apac/news-releases/nuevocor-closes-us45-million-series-b-financing-for-clinical-development-of-novel-mechanobiology-centered-therapy-for-cardiomyopathy-302446718.html?tc=eml_cleartime [Last accessed:
May 14 , 2025
].
8.Bluebird Bio . Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement . 2025 . Available from: https://investor.bluebirdbio.com/news-releases/news-release-details/carlyle-sk-capital-partners-and-bluebird-bio-amend-merger [Last accessed:
May 14 , 2025
].
9.Hovione . Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer . 2025 . Available from: https://www.hovione.com/press-room/press-release/hovione-and-firstgene-announce-strategic-collaboration-advance-virus-particle-platform-liver-cancer [Last accessed:
May 14 , 2025
].